These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Physical activity decreases the risk of stroke in middle-age men with left ventricular hypertrophy: 40-year follow-up (1961-2001) of the Seven Countries Study (the Corfu cohort). Pitsavos C, Panagiotakos DB, Chrysohoou C, Kokkinos P, Menotti A, Singh S, Dontas A, Seven Countries Study (the Corfu Cohort). J Hum Hypertens; 2004 Jul; 18(7):495-501. PubMed ID: 14985777 [Abstract] [Full Text] [Related]
48. [Cardiovascular disease in Chinese chronic renal insufficiency patients-epidemiology survey]. Hou FF, Ma ZG, Mei CL, Rong S, Huang SM, Liu XR, Yuan WJ, Guo YS, Wang L, He Q, Wang XL, Sang XH, Li XL. Zhonghua Yi Xue Za Zhi; 2005 Feb 23; 85(7):458-63. PubMed ID: 15854551 [Abstract] [Full Text] [Related]
49. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Weiner DE, Tabatabai S, Tighiouart H, Elsayed E, Bansal N, Griffith J, Salem DN, Levey AS, Sarnak MJ. Am J Kidney Dis; 2006 Sep 23; 48(3):392-401. PubMed ID: 16931212 [Abstract] [Full Text] [Related]
50. [Risk factors for myocardial remodeling at stage II-IV of chronic kidney disease]. Rudenko TE, Kutyrina IM, Shvetsov MIu. Ter Arkh; 2012 Sep 23; 84(6):21-6. PubMed ID: 22997913 [Abstract] [Full Text] [Related]
51. [Left ventricular hypertrophy in predialysis chronic kidney disease: impact of cardiomuscular stress markers]. Kimura T, Iio K, Obi Y, Hayashi T. Nihon Jinzo Gakkai Shi; 2007 Sep 23; 49(8):1007-13. PubMed ID: 18186229 [Abstract] [Full Text] [Related]
52. Anemia and left ventricular hypertrophy with renal function decline and cardiovascular events in chronic kidney disease. Chang JM, Chen SC, Huang JC, Su HM, Chen HC. Am J Med Sci; 2014 Mar 23; 347(3):183-9. PubMed ID: 23426086 [Abstract] [Full Text] [Related]
53. Additive interaction of metabolic syndrome and chronic kidney disease on cardiac hypertrophy, and risk of cardiovascular disease in hypertension. Iwashima Y, Horio T, Kamide K, Tokudome T, Yoshihara F, Nakamura S, Ogihara T, Rakugi H, Kawano Y. Am J Hypertens; 2010 Mar 23; 23(3):290-8. PubMed ID: 20044739 [Abstract] [Full Text] [Related]
54. Heart failure in patients with chronic kidney disease. Lisowska A, Musiał WJ. Rocz Akad Med Bialymst; 2004 Mar 23; 49():162-5. PubMed ID: 15631334 [Abstract] [Full Text] [Related]
55. Hemoglobin levels, cardiovascular disease, and left ventricular hypertrophy in patients with chronic kidney disease. Case study of the anemic patient. Butler KG. Nephrol Nurs J; 2002 Apr 23; 29(2):189-92. PubMed ID: 11997954 [Abstract] [Full Text] [Related]
56. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care. Ravera M, Noberasco G, Signori A, Re M, Filippi A, Cannavò R, Weiss U, Cricelli C, Deferrari G, Paoletti E. Am J Hypertens; 2013 May 23; 26(5):700-7. PubMed ID: 23391620 [Abstract] [Full Text] [Related]
57. Anemia as a risk factor for kidney function decline in individuals with heart failure. Bansal N, Tighiouart H, Weiner D, Griffith J, Vlagopoulos P, Salem D, Levin A, Sarnak MJ. Am J Cardiol; 2007 Apr 15; 99(8):1137-42. PubMed ID: 17437743 [Abstract] [Full Text] [Related]
58. Chronic kidney disease elicits excessive increase in left ventricular mass growth in patients at increased risk for cardiovascular events. Cioffi G, Tarantini L, Frizzi R, Stefenelli C, Russo TE, Selmi A, Toller C, Furlanello F, de Simone G. J Hypertens; 2011 Mar 15; 29(3):565-73. PubMed ID: 21150636 [Abstract] [Full Text] [Related]